Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)

To facilitate the achieving of the goal of "eliminating viral hepatitis as a major public health threat by 2030" set by the World Health Organization, the Chinese Society of Hepatology together with the Chinese Society of Infectious Diseases (both are branches of the Chinese Medical Association) organized a panel of experts and updated the guidelines for prevention and treatment of chronic hepatitis B in China (version 2022). With the support of available evidence, this revision of the guidelines focuses on active prevention, large scale testing, and expansion of therapeutic indication of chronic hepatitis B with the aim of reducing the hepatitis B related disease burden.

• PU
  Peking University First Hospital
• CM
  Capital Medical University
• CS
  Central South University
• FU
  Fudan University
• CM
  Chongqing Medical University
• ZU
  Zhejiang University
• XM
  Xinjiang Medical University
• SU
  Sichuan University
• CM
  China Medical University
• FM
  Fourth Military Medical University
• PU
  Peking University
• SM
  Southern Medical University
• NH
  Nanfang Hospital
• HH
  Huashan Hospital
• HM
  Hebei Medical University
• PU
  Peking University People's Hospital
• HP
  Henan Provincial People's Hospital
• CP
  Chinese People’s Liberation Army
• RH
  Ruijin Hospital
• XH
  Xiangya Hospital, Central South University
• WC
  West China Hospital, Sichuan University
• SH
  Shengjing Hospital